{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:08:19Z","timestamp":1749614899357,"version":"3.41.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ccm.2024.10.002","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T12:46:35Z","timestamp":1732884395000},"page":"21-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia"],"prefix":"10.1016","volume":"46","author":[{"suffix":"Jr.","given":"Thomas M.","family":"File","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2024.10.002_bib1","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial stratigies","volume":"158","author":"Ramirez","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2024.10.002_bib2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"author":"Kroger","key":"10.1016\/j.ccm.2024.10.002_bib3"},{"key":"10.1016\/j.ccm.2024.10.002_bib5","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial Prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.ccm.2024.10.002_bib6","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidate and recipients: guideline from the American society of transplantation infectious disease community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"journal-title":"Am Soc Transplant","article-title":"American Transplant Society Statement on COVID-19 vaccination in solid organ transplant recipients","year":"2021","key":"10.1016\/j.ccm.2024.10.002_bib7"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.002_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2023","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.ccm.2024.10.002_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/vaccines10050800","article-title":"Vaccination for the prevention of infection among immunocompromised patients: a concise review of recent systematic reviews","volume":"10","author":"See","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ccm.2024.10.002_bib11","doi-asserted-by":"crossref","first-page":"827242","DOI":"10.3389\/fimmu.2022.827242","article-title":"Insights form the early clinical trials assessing response to mRNA SARS-CoV-2 vaccination in immunocompromised patients","volume":"13","author":"Baron","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2024.10.002_bib12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/infdis\/jis487","article-title":"Influenza vaccination for immunocompromised patients: systemic review and meta-analysis by etiology","volume":"206","author":"Beck","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ccm.2024.10.002_bib13","first-page":"1322","volume":"67","author":"Kumar","year":"2018"},{"key":"10.1016\/j.ccm.2024.10.002_bib14","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1111\/ajt.17055","article-title":"Effect of influenza vaccination in solid organ transplant recipients","volume":"22","author":"Haboe","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ccm.2024.10.002_bib15","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2665-9913(19)30094-3","article-title":"Immunogenicity and safety of high-dose versus standard dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomized, double-blind active -comparator trial","volume":"2","author":"Colmegna","year":"2020","journal-title":"Lancet Rheum"},{"key":"10.1016\/j.ccm.2024.10.002_bib16","first-page":"590","article-title":"Alternative-dose versus standard-dose trivalent influenza vaccines for immunocompromised patients. A meta-analysis of randomized control trials","volume":"8","author":"Lai","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ccm.2024.10.002_bib17","first-page":"444","article-title":"Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations\u2014a systematic review and meta-analysis","volume":"83","author":"Leibovici-Weissman","year":"2021","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ccm.2024.10.002_bib18","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1016\/j.vaccine.2018.05.012","article-title":"Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharidevaccine in patients with chronic lymphocytic leukemia: a randomized study by the Swedish CLL group","volume":"36","author":"Svensson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2024.10.002_bib19","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/bloodadvances.2021006333","article-title":"Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis","volume":"6","author":"Teh","year":"2022","journal-title":"Blood Advances"},{"key":"10.1016\/j.ccm.2024.10.002_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000523753","article-title":"Vaccination for SARS-CoV-2 in hematological patients","volume":"145","author":"Riccardi","year":"2022","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ccm.2024.10.002_bib21","doi-asserted-by":"crossref","first-page":"e920","DOI":"10.1093\/cid\/ciab930","article-title":"Severe acute respiratory syndrome coronavirus 2 messenger RNA vaccines in allogenic hematopoietic stem cell transplant recipient: immunogenicity and reactogenicity","volume":"75","author":"Sherman","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2024.10.002_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12185-022-03325-9","volume":"115","author":"Tsushima","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ccm.2024.10.002_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood.2021014232","article-title":"Antibody response after 2 and 3 doses of mRNA vaccine in allogeneic hematopoietic transplant recipients","volume":"139","author":"Maillard","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ccm.2024.10.002_bib24","first-page":"e226822","article-title":"Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review and meta-analysis. JAMA net","volume":"5","author":"A Manothummetha","year":"2022","journal-title":"Open"},{"key":"10.1016\/j.ccm.2024.10.002_bib25","doi-asserted-by":"crossref","first-page":"e13706","DOI":"10.1111\/tid.13705","article-title":"Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients","volume":"23","author":"Aslam","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ccm.2024.10.002_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2021.09.055","article-title":"Serologic response to coronavirus disease 2019 vaccination in pati4ents with immune-mediated inflammatory disease: a systematic review and meta-analysis","volume":"162","author":"Sakuraba","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ccm.2024.10.002_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13045-022-01233-3","article-title":"Serologic response following SARS-CoV-2 vaccination in patients with cancer: a systematic review and meta-analysis","volume":"15","author":"Sakuraba","year":"2022","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.ccm.2024.10.002_bib28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/apt.16913","article-title":"Effectiveness and safety of SARS-CoV-2 vaccine in inflammatory bowel disease patients: a systematic revie, meta-analysis and meta-regression","volume":"55","author":"Bhurwal","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ccm.2024.10.002_bib29","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.annonc.2021.04.019","article-title":"Impaired immunogenicity of BMNT162b2 anti-SARS-Cov-2 vaccine in patients treated for solid tumors","volume":"32","author":"Barrier","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ccm.2024.10.002_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002036","article-title":"Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients","volume":"8","author":"Schietzel","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.ccm.2024.10.002_bib31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.annonc.2021.04.020","article-title":"Weak immunogenicity after a single dose of SARS-C0V-2 mRNA vaccine in treated cancer patients","volume":"32","author":"Palich","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ccm.2024.10.002_bib32","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1016\/j.vaccine.2023.05.038","article-title":"Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalization among immunocompromised adults: an observational study of real-world data across 10 US states form August- December 2021","volume":"41","author":"Embi","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ccm.2024.10.002_bib33","first-page":"77","article-title":"Early estimates of updated 2023-2024 COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults","volume":"73","author":"Link-Gellis","year":"2024","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.ccm.2024.10.002_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40001-022-00648-5","article-title":"Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis","volume":"27","author":"Nejad","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ccm.2024.10.002_bib35","first-page":"297","article-title":"Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis","volume":"84","author":"Marra","year":"2022","journal-title":"J\u00a0Infect"},{"issue":"RR-3","key":"10.1016\/j.ccm.2024.10.002_bib36","first-page":"1","article-title":"Pneumococcal vaccine for adults aged \u2265 19 years: recommendations of the advisory committee on immunization practices, United States, 2023","volume":"72","author":"Kogayashi","year":"2023","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.ccm.2024.10.002_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1473-3099(22)00526-6","article-title":"Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase \u00bd, randomized, double-blind, active comparator-controlled, multicenter, US-based trial","volume":"23","author":"Platt","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2024.10.002_bib38","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4161\/hv.7.9.15996","article-title":"Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults","volume":"7","author":"Musher","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.ccm.2024.10.002_bib39","first-page":"118","article-title":"Effectiveness of a third does of Pfizer0BioNTech and Moderna vaccines in preventing COVID-19 hospitalization among immunocompetent and immunocompromised adults-Unites States","volume":"71","author":"Tenforde","year":"2022","journal-title":"MMWR Rep"},{"key":"10.1016\/j.ccm.2024.10.002_bib40","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in Three doses of an mRNA vaccine in transplant recipients","volume":"385","author":"Jall","year":"2021","journal-title":"NEJM"},{"key":"10.1016\/j.ccm.2024.10.002_bib41","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.7326\/L21-0282","article-title":"Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients; a case series","volume":"174","author":"Werbel","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2024.10.002_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.838985","article-title":"Non-invasive monitoring for rejection in kidney transplant recipients after SARS-CoV-2 mRNA vaccination","volume":"13","author":"Al Jurdi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2024.10.002_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.vaccine.2012.10.063","article-title":"Pandemic unadjuvanted influenza A vaccine in dermatomyositis and polymyositis: immunogenicity independent of therapy and no harmful effect in disease","volume":"31","author":"Shinjo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2024.10.002_bib44","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/annrheumdis-2019-215086","article-title":"Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink","volume":"78","author":"Nakafero","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ccm.2024.10.002_bib45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/annrheumdis-2021-221490","article-title":"Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry","volume":"81","author":"Machado","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ccm.2024.10.002_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40001-024-01639-4","article-title":"Risk of flare or relapse in patients with immune-mediate diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis","volume":"29","author":"Shabani","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ccm.2024.10.002_bib47","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunizations Practices (ACIP)-United States, 2014-15 influenza season","volume":"63","author":"Grohskopf","year":"2014","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.ccm.2024.10.002_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.2023.9100","article-title":"A\u00a0new antiviral option for cytomegalovirus prevention after kidney transplant","volume":"330","author":"Raglow","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2024.10.002_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2023.9106","article-title":"Letermovir vs valganciclovir for prophylaxis of cytomegalovirus in high-risk kidney transplant recipients: a randomized clinical trial","volume":"330","author":"Limaye","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2024.10.002_bib50","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jgs.18122","article-title":"Cost-effectiveness of professional and mechanical oral care for preventing pneumonia in nursing home residents","volume":"71","author":"Okubo","year":"2023","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.ccm.2024.10.002_bib51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamainternmed.2023.6638","article-title":"Association between daily toothbrushing and hospital-acquired pneumonia: a systematic review and meta-analysis","volume":"184","author":"Ehrenzeller","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ccm.2024.10.002_bib52","article-title":"Lifestyle and comorbid conditions as risk factors for community-acquired pneumonia in outpatient adults","volume":"6","author":"Rivero-Calle","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.ccm.2024.10.002_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pulmoe.2019.10.003","article-title":"Pneumonia mortality, comorbidities matter?","volume":"26","author":"Hespanhol","year":"2020","journal-title":"Pulmonology"},{"key":"10.1016\/j.ccm.2024.10.002_bib54","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.294.21.2760","article-title":"Pneumonia in older adults","volume":"294","author":"File","year":"2005","journal-title":"JAMA"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523124000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523124000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:09:03Z","timestamp":1749553743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523124000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0272523124000911"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2024.10.002","relation":{},"ISSN":["0272-5231"],"issn-type":[{"type":"print","value":"0272-5231"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2024.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}